THE ROLE OF ADJUVANT ZOLEDRONIC ACID IN LOCALLY ADVANCED PROSTATE CANCER
Grant number: 1099149 | Funding period: 2016 - 2017
This project seeks to confirm the highly encouraging early findings from the RADAR prostate cancer trial so that the new treatments tested can be brought in to clinical practice. The trial involved 1071 men at 23 cancer treatment centres in ANZ who had developed extensive cancerous masses in their prostates but without evidence of spread. All received their trial treatments between 2003 and 2007. This project involves the collection and analysis of follow up information up until September 2017.
Related publications (1)
Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial
Swetha Sridharan, Allison Steigler, Nigel A Spry, David Joseph, David S Lamb, John H Matthews, Chris Atkinson, Keen-Hun Tai, Gillian Duchesne, David Christie, John Attia, Elizabeth G Holliday, James W Denham
BACKGROUND: It remains unclear whether eradication of oligometastases by stereotactic body radiation therapy or other means will r..